Safety and feasibility of liver maximum capacity assessment in patients undergoing transarterial chemoembolisation for hepatocellular carcinoma
George Clarke, Sofi Dhanaraj, Diana Hull, Michelle Panton et autres
0 citationsScientific Reports
Diana Hull
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
79Publications signalées
6899Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
COVID-19 Clinical Research StudiesLiver Disease Diagnosis and TreatmentAdipose Tissue and MetabolismHepatocellular Carcinoma Treatment and PrognosisSARS-CoV-2 and COVID-19 Research
Publications récentes
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Amr E. Abbas, Fatima Abbas, Kaja Abbas et autres
0 citationsThe Lancet Infectious Diseases
Data from Addition of Dendritic Cell Vaccination to Conditioning Cyclophosphamide and Chemoembolization in Patients with Hepatocellular Carcinoma: The ImmunoTACE Trial
Yuk Ting, Jianmin Zuo, Amanda Kirkham, Stuart M. Curbishley et autres
0 citations
Addition of a dendritic cell vaccine to conditioning cyclophosphamide and chemoembolisation to prolong progression-free survival in patients with hepatocellular carcinoma: the ImmunoTACE RCT
Yuk Ting, Amanda Kirkham, Stuart M. Curbishley, Anna Rowe et autres
0 citationsEfficacy and Mechanism Evaluation
Addition of Dendritic Cell Vaccination to Conditioning Cyclophosphamide and Chemoembolization in Patients with Hepatocellular Carcinoma: The ImmunoTACE Trial
Yuk Ting, Jianmin Zuo, Amanda Kirkham, Stuart M. Curbishley et autres
6 citationsClinical Cancer Research
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Amr E. Abbas, Fatima Abbas, Jonathan R. Abbas et autres
11 citationsThe Lancet Infectious Diseases
THU-339-YI UK validation of the simple cholestatic complaints score: a patient reported outcomes measure in primary sclerosing cholangitis
Nasir Hussain, Nadir Abbas, Khushpreet Bhandal, Penelope Rogers et autres
0 citationsJournal of Hepatology
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Amr E. Abbas, Fatima Abbas, Jaffar Abbas et autres
3 citationsEClinicalMedicine
THU-160 Long-term variability of pruritus in primary sclerosing cholangitis and implications for future clinical trial design
Nasir Hussain, James Ferguson, Nadir Abbas, Usha Gungabissoon et autres
1 citationJournal of Hepatology
LBP-046 A phase IIa basket clinical trial of allogeneic CD362-enriched umbilical cord-derived mesenchymal stromal cells (ORBCEL-CTM) in patients with primary sclerosing cholangitis and autoimmune hepatitis
Julian Yeh, Sheeba Khan, Sara Mahgoub, Victoria Homer et autres
0 citationsJournal of Hepatology
Vascular adhesion protein-1 blockade in primary sclerosing cholangitis: Open-label, multicenter, single-arm, phase II trial
Gideon M. Hirschfield, Katherine Arndtz, Amanda Kirkham, Yung‐Yi Chen et autres
8 citationsHepatology Communications
PREF-NET: a patient preference and experience study of lanreotide autogel administered in the home versus hospital setting among patients with gastroenteropancreatic neuroendocrine tumours in the UK
Mohid S. Khan, Kathryn Cook, Martin O. Weickert, Louise Davies et autres
3 citationsSupportive Care in Cancer
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.